Blue Trust’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
Blue Trust's AVIR Position: Q3 2026 in Review
Blue Trust held its Atea Pharmaceuticals (AVIR) position steady in Q3 2026 at 8,700 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1258.
Blue Trust first reported a position in AVIR in Q2 2022 and has held it in 18 quarters since. The position peaked at $63K in Q2 2022. 92 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.
- Blue Trust held 8,700 shares of Atea Pharmaceuticals worth $45.3K as of Q3 2026.
- Blue Trust left its Atea Pharmaceuticals share count unchanged in Q3 2026.
- Atea Pharmaceuticals made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1258 holding.
- Blue Trust first reported a position in Atea Pharmaceuticals in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Atea Pharmaceuticals position peaked at $63K in Q2 2022.
- 92 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.